Professor Esther Becker recognised in 2026 International 3Rs Prize awards
Kavli Oxford researcher Professor Esther Becker and her team have been recognised by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) for their innovative approach to studying medulloblastoma, the most common malignant brain tumour in children.
Their study, PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis, was highly commended in the 2026 International 3Rs Prize, which celebrates outstanding research advancing the replacement, reduction and refinement of animal use in science. The 2026 awards recognise innovative human-relevant experimental models across cancer research, immunotherapy and gene therapy.
Professor Becker and her colleagues use human stem cell-derived cerebellar organoids – miniature, three-dimensional models that reproduce key features of the developing human cerebellum – to investigate the early processes involved in brain tumour development. Traditional medulloblastoma research relies heavily on animal models. However, important differences between human and mouse brain development can limit how accurately these models reflect the origins and progression of the disease.
To address this challenge, the researchers developed human cerebellar organoids from induced pluripotent stem cells. Using CRISPR gene editing, they introduced loss-of-function mutations in PTCH1, a gene associated with a major subtype of medulloblastoma.
Organoids carrying a mutation in one copy of PTCH1 displayed features associated with early tumour development, including increased cell proliferation, genomic instability and activation of cancer-associated pathways. Importantly, aspects of their molecular profiles closely resembled those observed in patient tumours.
The findings highlight the potential of human cerebellar organoids to provide biologically relevant models for investigating the early stages of childhood brain cancer. This approach could open new opportunities to understand disease mechanisms and support future therapeutic research, while helping to reduce reliance on animal models.
Professor Becker said: ‘I'm deeply honoured that our paper has been recognised with a highly commended 3Rs Prize. This recognition reflects the excellent efforts of our entire team, their talent, perseverance, and shared commitment to advancing science while championing the principles of the 3Rs. I'm delighted that our work has been recognised in this way.’
Read the research article: PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis